BioSpace News Archive

Rentschler Biopharma, a leading global contract development and manufacturing organization for biopharmaceuticals, is celebrating its 150th anniversary this year, and the company continues to evolve and grow.

TerSera Therapeutics announced a new sponsorship with the Carcinoid Cancer Foundation and Alira Health to expand and optimize a holistic patient journey digital platform for patients with Neuroendocrine Tumors and Carcinoid Syndrome.

ExPLoRNA Therapeutics, a Polish biotech company revolutionizing mRNA vaccines and therapeutics with unprecedented translational efficiency, received funding from the Bill & Melinda Gates Foundation to further develop its unique mRNA technology.

Alliance Pharma, a global leader providing bioanalytical, DMPK, and CMC testing services in the pharmaceutical and biopharmaceutical industry, has opened its new 20,000-square-foot bioanalytical laboratory, Alliance Pharma Pty, Ltd., in Brisbane, Australia.

The global life science reagents market size was exhibited at USD 88.22 billion in 2022 and is expected to hold around USD 88.22 billion by 2030 growing at a CAGR of 8.3% from 2022 to 2030.

The global drug and gene delivery devices market size was exhibited at USD 438.36 billion in 2022 and is expected to hold around USD 815.06 billion by 2030 growing at a CAGR of 7.2% from 2022 to 2030.

The global cancer immunotherapy market size was exhibited at USD 96.93 billion in 2022 and is expected to hold around USD 277.1 billion by 2030 growing at a CAGR of 12.6% from 2022 to 2030.

The global clinical laboratory service market size was exhibited at USD 212.40 billion in 2022 and is expected to hold around USD 315.61 billion by 2030 growing at a CAGR of 5.1% from 2022 to 2030.

Aarvik Therapeutics announces a global license and assignment Agreement with NJ Bio, Inc. to secure a class of novel proprietary payloads with a wide range of potencies.

October xxth, 2022 – MDimune Inc., a Korean biotech company developing BioDroneTM platform technology based on cell-derived vesicles (CDVs), announced a research collaboration agreement with the Clear Vision Research Lab (CVR Lab) at the Australian National University (ANU), experts in retinal degenerations.